Home>US Stocks>Seagen Inc.
shareSHARE

SGEN

Seagen Inc.

Performance

Today’s LowNA
    Today’s HighNA
    52W LowNA
      52W HighNA
      Open PricePrev. CloseVolumeAvg. Volume
      NANANANA

      Company Statistics

      Market CapP/B RatioP/E RatioEnterprise Value
      $28.45 B8.2046.40$27.95 B
      Div. YieldBook ValueEPS(TTM)ROE
      NA19.953.5126.30%

      About the Company

      Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgki
      Organisation
      Seagen Inc.
      Industry
      Biotechnology
      Headquarters
      Bothell, WA
      ⓒ 2016-2021 Groww. All rights reserved, Built with in India
      ABOUT GROWW
      keyboard_arrow_down